Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

GBE1 Antikörper (AA 101-200) (Biotin)

GBE1 Reaktivität: Human WB, ELISA, IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal Biotin
Produktnummer ABIN1700304
  • Target Alle GBE1 Antikörper anzeigen
    GBE1 (Glucan (1,4-alpha-), Branching Enzyme 1 (GBE1))
    Bindungsspezifität
    • 14
    • 7
    • 7
    • 6
    • 6
    • 5
    • 4
    • 1
    • 1
    • 1
    • 1
    AA 101-200
    Reaktivität
    • 53
    • 11
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 44
    • 9
    Kaninchen
    Klonalität
    • 47
    • 6
    Polyklonal
    Konjugat
    • 21
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser GBE1 Antikörper ist konjugiert mit Biotin
    Applikation
    • 44
    • 20
    • 16
    • 13
    • 13
    • 6
    • 6
    • 5
    • 4
    • 3
    • 2
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
    Homologie
    Human,Mouse,Rat,Rabbit
    Aufreinigung
    Purified by Protein A.
    Immunogen
    KLH conjugated synthetic peptide derived from human GBE1
    Isotyp
    IgG
    Top Product
    Discover our top product GBE1 Primärantikörper
  • Applikationshinweise
    WB 1:300-5000
    IHC-P 1:200-400
    IHC-F 1:100-500
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C for 12 months.
    Haltbarkeit
    12 months
  • Target
    GBE1 (Glucan (1,4-alpha-), Branching Enzyme 1 (GBE1))
    Andere Bezeichnung
    GBE1 (GBE1 Produkte)
    Synonyme
    glgBII antikoerper, APBD antikoerper, GBE antikoerper, GSD4 antikoerper, 2310045H19Rik antikoerper, 2810426P10Rik antikoerper, D16Ertd536e antikoerper, 1,4-alpha-glucan branching protein GlgB antikoerper, 1,4-alpha-glucan branching protein antikoerper, glycogen branching protein antikoerper, glycogen branching enzyme antikoerper, 1,4-alpha-glucan-branching protein antikoerper, glycogen branching enzyme; BE; 1,4-alpha-D-glucan:1,4-alpha-D-glucan 6-glucosyl-transferase antikoerper, 1,4-alpha-glucan branching enzyme 1 antikoerper, glucan (1,4-alpha-), branching enzyme 1 antikoerper, glgB antikoerper, ECs4277 antikoerper, SCO7332 antikoerper, Synpcc7942_1085 antikoerper, AZC_4116 antikoerper, Sros_8169 antikoerper, Despr_0975 antikoerper, GBE1 antikoerper, Gbe1 antikoerper
    Hintergrund

    Synonyms: 1,4 alpha glucan branching enzyme, 4-alpha-glucan-branching enzyme, amylo 1,4 to 1,6 transglucosidase, amylo 1,4 to 1,6 transglycosylase, Andersen disease, Brancher enzyme, GBE 1, GBE, GBE1, gGlucan 1,4 alpha , branching enzyme 1, GLGB_HUMAN, Glucan 1,4 alpha branching enzyme, Glycogen branching enzyme, Glycogen storage disease type IV, Glycogen-branching enzyme, OTTHUMP00000213788, OTTHUMP00000213833.

    Background: GBE1 is a 702 amino acid protein that is expressed at high levels in muscle and liver and is involved in glycogen biosynthesis. Existing as a monomer, GBE1 catalyzes the transfer of alpha-1,4-linked glucosyl units from the outer end of a glycogen chain to an alpha-1,6 position on a neighboring glycogen chain and, via this catalytic activity, plays an essential role in glycogen accumulation. Defects in the gene encoding GBE1 are the cause of glycogen storage disease type 4 (GSD4) and adult polyglucosan body disease (APBD), the first of which is a metabolic disorder that is associated with the accumulation of polysaccharides and is characterized by liver disease during childhood. Unlike GSD4, APBD is a late-onset disorder that affects the central and peripheral nervous systems and is characterized by cognitive impairment, pyramidal tetraparesis and peripheral neuropathy.

    Gen-ID
    2632
    Pathways
    Cellular Glucan Metabolic Process
Sie sind hier:
Kundenservice